Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity Biotech Investing
Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments Biotech Investing
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases Biotech Investing
